Prognostic Significance of Survivin in Pediatric Acute Lymphoblastic Leukemia

  • Asmaa M. Esh
  • Maha Atfy
  • Nashwa A. Azizi
  • Mohamed M. El Naggar
  • Ebtesam E. Khalil
  • Layla Sherief
Original Article


Impaired apoptosis is mediated by members of the inhibitor of apoptosis proteins (IAP) family such as survivin. Survivin was described in number of different tumors and found to correlate with poor prognosis in a variety of cancers including hematologic malignancies. The aim of this study was to determine survivin in pediatric ALL and compare it with clinical and hematological findings, response to therapy and outcome. Flowcytometry was used for detection of intracellular survivin and determine its mean fluorescence intensity (MFI) in bone marrow mononuclear cells. Patients were followed up for 28 months after induction therapy. Survivin was detected in 63.3% of the patients BM. In spite of no association of survivin levels with established risk factors (P > 0.05) except with high WBC, there was significant higher level of survivin expression in high risk group patients when patients were stratified into high and standard risk groups. According to response to induction therapy, there was no significant difference, in survivin level between patients who achieved CR, RD and ED. However, patients suffering relapse of the disease, had a significant higher basal level of survivin than patients still in remission. Over expression of survivin is a candidate parameter to determine poor prognosis in ALL patients and it may serve to refine treatment stratification with intensification of therapy in those patients prone to relapse.


Pediatric ALL Survivin Prognosis 


  1. 1.
    Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462CrossRefPubMedGoogle Scholar
  2. 2.
    Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46–54CrossRefPubMedGoogle Scholar
  3. 3.
    Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO Eur Mol Biol Organ J 12:461–468Google Scholar
  4. 4.
    Miyashita T, Krajewski S, Krajewski M et al (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799–1805PubMedGoogle Scholar
  5. 5.
    Deveraux QL, Reed JC (1999) IPA family proteins: suppressors of apoptosis. Genes Dev 13:239–252CrossRefPubMedGoogle Scholar
  6. 6.
    Altieri DC, Marchisio PC, Marchisio PC (1999) Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79:1327–1333PubMedGoogle Scholar
  7. 7.
    Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921CrossRefPubMedGoogle Scholar
  8. 8.
    Swana HS, Grossman D, Anthony JN et al (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. Lancet 341:452–453Google Scholar
  9. 9.
    Yu J, Leung WK, Ebert MPA et al (2002) Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer 87:91–97CrossRefPubMedGoogle Scholar
  10. 10.
    Carter BZ, Milella M, Altieri DC, Andreef M (2001) Cytokine-regulated expression of survivin in myeloid leukemia. Blood 97:2784–2790CrossRefPubMedGoogle Scholar
  11. 11.
    Mori A, Wada H, Nishimura Y et al (2002) Expression of the antiapoptosis gene survivin in human leukemia. Int J Hematol 75:161–165CrossRefPubMedGoogle Scholar
  12. 12.
    Kawasaki H, Altieri DC, Lu CD et al (1998) Inhibition of apoptosis by surviving predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071–5074PubMedGoogle Scholar
  13. 13.
    Adida-Adida C, Berrebi D, Paichmaur M et al (1998) Anti-apoptosis gene survivin, and prognosis of neuroblastoma. Lancet 351:882–883CrossRefGoogle Scholar
  14. 14.
    Adida C, Haioun C, Gaulard P et al (2000) Prognostic significance of survivin in diffuse large B-cell lymphomas. Blood 96:1921–1925PubMedGoogle Scholar
  15. 15.
    Aref S, Salama O, Al-Tonbary Y et al (2004) Assessment of Bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia. Hematology 9(2):113–121CrossRefPubMedGoogle Scholar
  16. 16.
    Holleman A, Den Boer ML, Kazemier KM et al (2003) Resistance to different clases of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood 102:4541–4546Google Scholar
  17. 17.
    Schimmer AD, Hedley DW, Penn LZ et al (2003) Receptor and mitochondrial-mediated apoptosis in acute leukemia: a translational view. Blood 98:3541–3553CrossRefGoogle Scholar
  18. 18.
    Tamm I, Wang Y, Sausville E et al (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315–5320PubMedGoogle Scholar
  19. 19.
    Harms DO, Janka-Schaub GE et al (2000) Cooperative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia 14:2234–2239CrossRefPubMedGoogle Scholar
  20. 20.
    Troeger A, Siepermann M, Escherich G et al (2007) Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia. Haematologica 92:1043–1050CrossRefPubMedGoogle Scholar
  21. 21.
    Rubnitz JE. Acute lymphoblastic Leukemia. Accessed 7 Nov 2009
  22. 22.
    Seabright M (1971) A rapid banding technique for human chromosomes. Lancet 30:971CrossRefGoogle Scholar
  23. 23.
    Schmid I, Uittenbogaart CH, Giorgi JV (1991) A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry 12(3):274–285CrossRefGoogle Scholar
  24. 24.
    Paydas S, Tanriverdi K, Yavuz S et al (2003) survivin and aven: two distinct antiapoptotic signals in acute leukemias. Ann Oncol 14:1045–1050CrossRefPubMedGoogle Scholar
  25. 25.
    Li F, Ambrosini G, Chu EY et al (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584CrossRefPubMedGoogle Scholar
  26. 26.
    Holleman A, den Boer ML, de Menezes RX et al (2006) The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 107:769–776CrossRefPubMedGoogle Scholar
  27. 27.
    Hayashibara T, Yamada Y, Nakayama S et al (2002) Resveratrol induces down regulation in surviving expression and apoptosis in HTLV- 1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy. Nutr Cancer 44:193–201CrossRefPubMedGoogle Scholar
  28. 28.
    Carter BZ, Wang RY, Schober WD et al (2003) Targeting survivin expression induces cell proliferation defect and subsequent cell death involving mitochondrial pathway in myeloid leukemic cells. Cell Cycle 2:488–493CrossRefPubMedGoogle Scholar

Copyright information

© Indian Society of Haematology & Transfusion Medicine 2011

Authors and Affiliations

  • Asmaa M. Esh
    • 1
  • Maha Atfy
    • 1
  • Nashwa A. Azizi
    • 1
  • Mohamed M. El Naggar
    • 1
  • Ebtesam E. Khalil
    • 1
  • Layla Sherief
    • 2
  1. 1.Department of Clinical Pathology, Faculty of MedicineZagazig UniversityZagazigEgypt
  2. 2.Department of Pediatric, Faculty of MedicineZagazig UniversityZagazigEgypt

Personalised recommendations